What is it?
Walk into any pharmacy or health food shop in the UK and there is an entire aisle of supplements promising to support cholesterol, protect your heart, or promote healthy lipid levels. Fish oil capsules, plant sterol drinks, red yeast rice tablets, garlic extract, niacin — the options can feel overwhelming. And they're not cheap.
Millions of people take these products every year, often hoping to avoid or reduce prescription medication, or simply to do something extra for their heart health. The UK supplement market is worth billions of pounds annually. But the critical question is: what does the scientific evidence actually say?
The honest answer is nuanced. Some supplements have genuinely meaningful evidence behind them. Others have been repeatedly shown to perform no better than a placebo in rigorous trials. And a small number carry real safety concerns that are widely underappreciated.
This article works through the main cholesterol-related supplements one by one — looking at what they are, what effect they actually have on cholesterol numbers, and what is known (and not known) about whether that translates into reduced heart disease risk.
Key Terms
Why does it matter?
Millions of people take cholesterol supplements every year, often spending significant money on products with limited or no proven benefit for reducing heart attack or stroke risk. Understanding what the evidence actually shows is an important part of making informed decisions about heart health.
A critical distinction runs through this entire topic: lowering cholesterol numbers on a blood test is not the same as reducing heart attack or stroke risk. Even if a supplement lowers LDL, it may not translate into the clinical benefits that well-studied medicines like statins have demonstrated in large outcome trials.
What your doctor might do
When cholesterol supplements are raised in a GP appointment, the conversation will typically turn first to whether overall cardiovascular risk has been properly assessed — since that determines what kind of intervention, if any, is actually warranted. Here is what the evidence shows for the most commonly used supplements, and how they fit into clinical practice.
Plant Sterols & Stanols (Phytosterols)
Strongest EvidenceWhat they are: Plant-derived compounds found naturally in vegetable oils, nuts, and grains. Added to products like Benecol and Flora ProActiv drinks, spreads, and yoghurts — and also sold as tablet supplements.
The evidence: A large meta-analysis of 124 studies found that consuming around 2 grams per day was associated with an LDL reduction of approximately 7–12%. This is the best-evidenced supplement effect on LDL — real, consistent, and well-replicated.
The important caveat: Lowering LDL with plant sterols has not been shown to reduce the risk of heart attacks or strokes in large outcome trials. UK guidelines therefore do not currently recommend them specifically for cardiovascular disease prevention. They are not a substitute for prescribed medication in those at significant risk.
Red Yeast Rice
Caution AdvisedWhat it is: Rice fermented with the mould Monascus purpureus. The fermentation produces monacolin K — which is chemically identical to the prescription statin lovastatin (Mevacor).
How it works: In exactly the same way as a statin — it inhibits HMG-CoA reductase. This is not a "natural" alternative to a statin; in biochemical terms, it is a statin.
Safety concerns: Because monacolin K is identical to a prescription drug, it carries the same risk of side effects: muscle pain, muscle breakdown (rhabdomyolysis), and liver damage. In January 2025, the European Food Safety Authority (EFSA) concluded there is no dose of monacolin K from red yeast rice that can be considered safe as a food supplement. The EU revoked the health claim for monacolin K in August 2024. Products available online may contain unregulated and unpredictable amounts of active ingredient.
Omega-3 / Fish Oil
NuancedWhat it is: Supplements containing EPA and DHA, the omega-3 fatty acids found in oily fish. Widely sold for "heart health."
On cholesterol specifically: Standard fish oil supplements do not lower LDL cholesterol — and at some doses may actually increase it slightly. Fish oil does meaningfully lower triglycerides at high doses.
On heart attack and stroke risk: The evidence is genuinely mixed. A large 2024 UK Biobank study found fish oil supplements may increase risk of atrial fibrillation (irregular heart rhythm) in those without established heart disease, while potentially benefiting those who already have it. The British Heart Foundation does not recommend fish oil supplements for general heart disease prevention.
Garlic Extract
Weak EvidenceThe evidence: Not encouraging. A well-designed Stanford University trial found that raw garlic or garlic supplements taken almost daily for six months had no meaningful effect on LDL cholesterol. In the SPORT trial, garlic supplements actually slightly increased LDL compared to placebo.
Garlic in food — as part of a Mediterranean-style diet — remains a sensible dietary choice. As an isolated supplement for cholesterol management, the evidence is not there.
Niacin (Vitamin B3)
Not RecommendedThe problem: The cholesterol effect of niacin is only seen at prescription doses significantly higher than those available over the counter. At lower doses, it has no meaningful cholesterol effect. At the doses that do have an effect, niacin can cause intense skin flushing — and large trials have not shown it to reduce heart attacks or strokes when added to statin therapy.
A newer concern: A 2024 study in Nature Medicine found that excess niacin intake may raise the risk of cardiovascular events through a previously unknown inflammatory pathway. This is important context for anyone considering high-dose niacin supplementation.
At a glance: how the supplements compare
| Supplement | Lowers LDL? | Lowers Triglycerides? | Reduces Heart Events? | Key Safety Concern? |
|---|---|---|---|---|
| Plant sterols/stanols | ✓ Yes (7–12%) | ✗ Minimal | ? Not proven | None known at recommended doses |
| Red yeast rice | ✓ Yes (if high monacolin) | ~ Some | ? Limited data | Muscle damage, liver injury — same as statins |
| Fish oil (omega-3) | ✗ No / slight ↑ | ✓ Yes (dose-dependent) | ~ Mixed evidence | Possible ↑ atrial fibrillation risk |
| Garlic extract | ✗ No | ✗ No | ✗ No | None significant |
| Niacin (high dose) | ~ Some (prescription doses only) | ~ Some | ✗ Not shown | Flushing, possible cardiovascular harm |
| Cinnamon / Turmeric | ✗ No | ✗ No | ✗ No | None significant at supplement doses |
Red yeast rice is often chosen as a "natural" alternative to statins. But the active compound, monacolin K, is chemically identical to the prescription statin lovastatin (Mevacor). The risks — including serious muscle breakdown and liver damage — are the same. The key difference is that supplements are not regulated in the same way as medicines, so the amount of active ingredient in any given product cannot be verified.
What is discussed in UK clinical practice
- Overall cardiovascular risk matters more than any single cholesterol number. A GP will typically discuss the full risk profile using a tool like QRISK3 before recommending any cholesterol-lowering strategy.
- For those at meaningful cardiovascular risk, the evidence base strongly favours statins over supplements. Statins (atorvastatin/Lipitor, rosuvastatin/Crestor) typically reduce LDL by 30–50% and have decades of evidence showing reduced heart attacks and strokes.
- Plant sterols may be a reasonable addition for mildly elevated cholesterol and low overall cardiovascular risk — alongside dietary and lifestyle changes, not instead of them.
- Red yeast rice is relevant to clinical conversations because it can interact with other medications and carries the same risks as a prescribed statin — the same discussion that would apply to statin prescribing applies here.
- Fish oil at high prescribed doses has a specific role in treating very high triglycerides — a conversation for a GP. Over-the-counter supplements for general heart health are not currently recommended by UK guidelines.
- Supplement use — including over-the-counter products — is relevant when any new medication is being considered, as interactions can occur. This is part of the standard medicines review conversation.
What the research shows
The SPORT trial1 at Cleveland Clinic randomly assigned 190 adults aged 40–75 to receive either rosuvastatin (Crestor) 5mg, a placebo, or one of six popular supplements — fish oil, cinnamon, garlic, turmeric, plant sterols, or red yeast rice — for 28 days. The statin reduced LDL by an average of 37.9%. All six supplements performed no differently from placebo on LDL reduction. Garlic actually slightly increased LDL versus placebo.
A large meta-analysis examining 124 randomised controlled trials2 found that consuming 0.6–3.3g per day of plant sterols or stanols reduced LDL cholesterol by an average of 6–12%, with the effect plateauing above 3g per day. The British Dietetic Association cites 2g per day as associated with a 7.5–12% LDL reduction. Importantly, no large randomised trial has yet demonstrated that this LDL reduction translates into fewer heart attacks or strokes.
In January 2025, the European Food Safety Authority (EFSA)3 concluded that there is no safe dose of monacolin K in food supplements — individual cases of serious adverse reactions, including rhabdomyolysis (severe muscle breakdown — a medically significant pattern warranting prompt assessment) and acute liver injury, have been reported at doses as low as 3mg per day. The EU revoked the health claim for monacolin K in August 2024. UK regulations (MHRA) may treat products with significant monacolin content as unlicensed medicines.
A large UK Biobank cohort study4 including over 415,000 adults found that regular fish oil supplement use was associated with an increased risk of developing atrial fibrillation (AF — an irregular heart rhythm) and stroke in people without pre-existing cardiovascular disease, while appearing to reduce the risk of progression to more serious events in those already with heart conditions. This is an observational finding and cannot prove causation, but it substantially complicates the "safe default supplement" framing of fish oil.
Statins — when used appropriately for people at meaningful cardiovascular risk — have one of the most robust evidence bases in all of medicine.5 Over decades and in trials involving hundreds of thousands of people, they have been shown to substantially reduce heart attacks, strokes, and cardiovascular deaths. No cholesterol-lowering supplement has an evidence base remotely comparable for clinical outcomes. This does not mean supplements have no role — but it does mean the comparison is not equivalent.
Plant sterols genuinely lower LDL on a blood test. But lowering LDL is only valuable if it reduces the risk of a heart attack or stroke. For statins, this link has been demonstrated in large, long-term trials. For plant sterol supplements, the number changes — but the proven outcome benefit is not yet there. This distinction matters when weighing up the value of a supplement versus prescribed treatment.
Putting it all together
The supplement market is built on a powerful idea — that there must be a gentler, more "natural" path to the same health benefit as prescription medicine. For cholesterol, this idea is appealing but the evidence tells a more complicated story.
Plant sterols stand out as the supplement with the best evidence for genuinely lowering LDL cholesterol, and they are safe at recommended doses. Fish oil has a clear effect on triglycerides — not LDL — and the picture on heart disease prevention is genuinely mixed. Red yeast rice is effectively an unregulated statin, with the same mechanism and the same risks, but without the quality controls that apply to licensed medicines.
For other popular supplements — garlic, cinnamon, turmeric — the evidence does not support their use for cholesterol management, despite widespread marketing for exactly that purpose.
For people at meaningful cardiovascular risk, whether any intervention is appropriate — and which one — is a conversation for you to have with your GP or healthcare professional based on the full picture of individual risk.
References
This article is for health education only. It is not a substitute for medical advice, diagnosis, or treatment. Anything personally relevant is a conversation for you to have with your GP or healthcare professional.